DAVID F HALE Insider Trading
Get free email notifications about insider trading for DAVID F HALE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID F HALE. DAVID F HALE is a Director in MICROMET, INC. ($MITI) and a President and CEO in MICROMET, INC. ($MITI) and a Chairman in BIOCEPT INC ($BIOC) and a Director in BIOCEPT INC ($BIOC) and a Director in SANTARUS INC ($SNTS) and a Director in GTX INC /DE/ ($GTXI) and a Director in METABASIS THERAPEUTICS INC ($MBRX) and a Director in Pernix Sleep, Inc. ($SOMX) and a Director in Conatus Pharmaceuticals Inc. ($CNAT).
Address: 2110 RUTHERFORD ROAD CARLSBAD 92008 CA
Companies in which DAVID F HALE is an Insider
BIOCEPT INC
Trading Symbol: BIOCIndustry: SERVICES-MEDICAL LABORATORIES [8071]
Position of DAVID F HALE: Director, Chairman
Holdings: 3,477 shares
Current Value: $5,459
Latest Transaction: Jun 12 2020
$BIOC Market Capitalization: $29.57M
$BIOC Previous Close: $1.57
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Histogen Inc.
Trading Symbol: HSTOIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID F HALE: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jul 01 2019
$HSTO Market Capitalization: $127.38M
$HSTO Previous Close: $5.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
METABASIS THERAPEUTICS INC
Trading Symbol: MBRXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID F HALE: Director
Holdings: 14,140 shares
Current Value: $25,452
Latest Transaction: May 19 2005
$MBRX Market Capitalization: $18.08M
$MBRX Previous Close: $1.80
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MICROMET, INC.
Trading Symbol: MITIIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DAVID F HALE: Director, President and CEO
Holdings: 135,831 shares
Latest Transaction: Mar 23 2007
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Oncternal Therapeutics, Inc.
Trading Symbol: ONCTIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID F HALE: Director
Holdings: 699,406 shares
Current Value: $3,902,685
Latest Transaction: Jun 12 2020
$ONCT Market Capitalization: $86.92M
$ONCT Previous Close: $5.58
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Pernix Sleep, Inc.
Trading Symbol: SOMXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID F HALE: Director
Holdings: 237,307 shares
Latest Transaction: Dec 23 2005
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SANTARUS INC
Trading Symbol: SNTSIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID F HALE: Director
Holdings: 3,500 shares
Latest Transaction: Jan 30 2007
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of DAVID F HALE
Sentiment: All, BIOC, HSTO, MBRX, MITI, ONCT, SOMX, SNTS
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 12 2020 | BIOC | BIOCEPT INC | HALE DAVID F | Director | Sell | S | 0.56 | 556 | 309 | 867 | 1.4 K to 867 (-39.07 %) |
Jun 12 2020 | BIOC | BIOCEPT INC | HALE DAVID F | Director | Sell | S | 0.56 | 556 | 309 | 867 | 1.4 K to 867 (-39.07 %) |
Jun 12 2020 | BIOC | BIOCEPT INC | HALE DAVID F | Director | Sell | S | 0.55 | 445 | 247 | 112 | 557 to 112 (-79.89 %) |
Jun 12 2020 | BIOC | BIOCEPT INC | HALE DAVID F | Director | Sell | S | 0.55 | 445 | 247 | 112 | 557 to 112 (-79.89 %) |
Jun 12 2020 | BIOC | BIOCEPT INC | HALE DAVID F | Director | Sell | S | 0.56 | 159 | 89 | 3,477 | 3.6 K to 3.5 K (-4.37 %) |
Jun 12 2020 | BIOC | BIOCEPT INC | HALE DAVID F | Director | Sell | S | 0.56 | 159 | 89 | 3,477 | 3.6 K to 3.5 K (-4.37 %) |
Jun 12 2020 | ONCT | Oncternal Therapeu ... | HALE DAVID F | Director | Option Exercise | A | 2.94 | 22,500 | 66,150 | 22,500 |